The CFAR International Mentored Scientist Award in HIV/AIDS is currently being offered during the Spring 2024 UCSF Resource Allocation Program (RAP) Cycle, opens Monday, January 29, 2024
Deadline: Monday. MARCH 4, 2024 (2:00 pm PST)
The International Mentored Scientist Award seeks to provide a mentored career development opportunity in HIV research for international investigators affiliated with UCSF. Applicants for this award must indicate a UCSF-affiliated faculty research mentor(s) in HIV who will commit to guiding the applicant for the application process and throughout the duration of the proposed project. Project proposals should be geared toward the interests of the applicant (e.g., clinical, basic, implementation science and/or behavioral-epidemiological research) and focus on HIV research in the investigator’s home country.
Eligibility
Researchers (all levels), post-doctoral fellows, and trainees located at a UCSF-affiliated foreign institution who have not received an NIH R01- equivalent grant in HIV/AIDS are eligible. Please note that CFAR is not allowed to provide funding to any investigators who have received HIV-related R01 awards. More senior faculty members may apply only if they are newly entering the field of HIV research.
Designation of Mentor (Critical)
Mentoring is critical to the training component of the CFAR International Mentored Scientist awards. All International Mentored award applications require a faculty research mentor from UCSF or a UCSF-affiliated institution (https://cfar.ucsf.edu/about/partners). Applications without a mentor will be disqualified.
Applicants must identify their UCSF-affiliated mentors and arrange to receive mentor advice and guidance on the research portion of their application well before it is submitted (typically at least two months before the RAP deadline). CFAR is no longer available to assist with mentor identification.
Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.
The award amount is $30,000 in direct costs for one year.
For more detailed information about this RFA, please see the RAP Portal.
International Mentored Science Awardees
33 Awards
-
Frequency and evolution of HIV-1 drug resistance among Ugandan children receiving antiretroviral therapy
Frequency and evolution of HIV-1 drug resistance among Ugandan children receiving antiretroviral therapy
Abstract
Publications:
-
Family Planning Use Among Female Clients Attending The HIV/AIDS Clinic In Mbarara University Teaching Hospital
Family Planning Use Among Female Clients Attending The HIV/AIDS Clinic In Mbarara University Teaching Hospital
Abstract
The use of family planning has been shown to have strong potential to reduce new HIV infections due to unwanted fertility in Uganda. Most prevention of mother to child transmission PMTCT efforts to date have prioritized the provision of antiretroviral prophylaxis to HIV infected pregnant women, leaving voluntary contraception an underutilized approach despite evidence that preventing unintended pregnancies in the HIV infected women is an effective strategy for reducing HIV positive births and is cost effective.
-
Examining Sexual Concurrency and Sexual Networks among Married Fishermen Couples in Kisumu District, Kenya
Examining Sexual Concurrency and Sexual Networks among Married Fishermen Couples in Kisumu District, Kenya
Abstract
Determining the prevalence of sexual concurrent partnerships among married couples and the structure and characteristics of the resultant sexual networks is crucial in designing appropriate HIV prevention interventions. In this study we seek to: (a) identify the types and extent of concurrent sexual partnerships and, (b) elucidate the structure and characteristics of sexual networks that result from concurrent sexual partnerships among married fishermen couples in Kisumu, Kenya.
-
Optimizing Nevirapine Dosing in Patients Co-infected with Tuberculosis and HIV in Harare, Zimbabwe
Optimizing Nevirapine Dosing in Patients Co-infected with Tuberculosis and HIV in Harare, Zimbabwe
Abstract
Nevirapine (NVP) is the primary antiretroviral (ART) available in Zimbabwe. However, its use as first line ART is complicated by interactions with rifampicin (RIF), the primary drug available for tuberculosis (TB). In some cases ART treatment is delayed or avoided in TB co-infected patients. Previous studies of the effect of RIF on NVP pharmacokinetic (PK) exposure has been inconclusive, failing to generate specific recommendations regarding co-treatment. Moreover, PK and safety data for NVP with RIF have not been generated in our population in Zimbabwe.
-
A study to evaluate the acceptability and feasibility of providing integrated HIV and maternal and child health services thorough well child services in KwaZulu Natal, South Africa
A study to evaluate the acceptability and feasibility of providing integrated HIV and maternal and child health services thorough well child services in KwaZulu Natal, South Africa
Abstract
In the KwaZulu-Natal (KZN) province of South Africa (SA), where antenatal HIV prevalence is 39.5%, there has been substantial impact of programs to prevent mother-to-child transmission (PMTCT) of HIV.However, despite the recognized benefits of early ART initiation for HIV-infected infants and maternal health care, there is substantial loss to follow-up of HIV-infected mothers and their infants after delivery. Barriers to effective utilization of postnatal HIV care and treatment services include logistical factors, competing demands, and psychological factors such as fear of stigmatization.
-
Development of a Combination HIV Prevention Intervention for Transgender Women in Peru
Development of a Combination HIV Prevention Intervention for Transgender Women in Peru
Abstract
Transgender women are the population most affected by the HIV/AIDS epidemic in Peru because of issues that occur at individual, interpersonal, socio-cultural, and structural levels, as our team has demonstrated in previous research. A combination, multilevel intervention approach is needed incorporating strategies in order to address internalized oppression, self-regulation abilities, and sexual self-knowledge, along with biomedical approaches to HIV prevention. This proposal aims to conduct a one year qualitative study leading to an NIH grant to develop such an intervention strategy.
-
Adaptation of a Male Partner Educational Intervention Tool for Vaginal Microbicide Trials
Adaptation of a Male Partner Educational Intervention Tool for Vaginal Microbicide Trials
Abstract
In Sub-Saharan Africa, high hypothetical acceptability of vaginal microbicide trials among women has often been dampened by low male partner support. Formative work recently carried out among women in Kisumu, Kenya indicate that despite a high willingness (80%) to participate in upcoming vaginal microbicide trials, more than a third of the interviewees either did not think their partners would support their trial participation or were unsure of his support.
-
Mechanisms of CD4 T-cell death among HIV-infected, HAART-treated African adults displaying poor CD4 T-cell reconstitution despite effective viral suppression
Mechanisms of CD4 T-cell death among HIV-infected, HAART-treated African adults displaying poor CD4 T-cell reconstitution despite effective viral suppression
Abstract
Most HIV-infected subjects exhibit a progressive rise in CD4 T-cell counts after initiation of highly active antiretroviral therapy (HAART). However, a subset of individuals exhibit very poor CD4 T cell recovery despite effective control of viremia. Increased activation-induced programmed cell death of CD4 T cells has been proposed as a mechanism underlying poor immune recovery. We propose to perform a nested case control study utilizing a rural cohort of HIV-infected adults whose CD4 T-cell counts have remained low (<50 cell increase) despite HAART for at least six months.
-
Evaluation of the Dynamics and Immuno-Virology of Human Papillomavirus Infections among Fishermen in Kisumu, Kenya
Evaluation of the Dynamics and Immuno-Virology of Human Papillomavirus Infections among Fishermen in Kisumu, Kenya
Abstract
Human papillomavirus (HPV) is associated with cervical, vulvar, anal and penile cancers. High incidence rates of these cancers are observed in Africa compared to other parts of the world. Severa studies have implicated that the sexual behavior of the male partner is or even more important than women?s personal sexual behavior in predicting her risk of HPV associated cancers. Little is known about the natural history of HPV infections among men; thus hampering efforts to control infection in both men and women.
-
Investigation of Pediatric HIV Disclosure in Kampala, Uganda
Investigation of Pediatric HIV Disclosure in Kampala, Uganda
Abstract
There are more than 3 million children 15 years estimated to be living with HIV, with almost 90% residing in sub-Saharan Africa (SSA). This presents a growing challenge to health providers and caregivers concerning the disclosure of HIV serostatus to infected children. Studies conducted in SSA have indicated that only 2% to 37.8% of HIV-infected children 15 years know their HIV status. Despite formal recommendations for disclosure, there are no tested models for supporting caregivers and HIV-infected children in SSA through the process of disclosure.